Brendan Teehan, EVP, COO, HEAD OF COMMERCIAL at ACADIA PHARMACEUTICALS INC (ACAD), sold 19,068 shares at $15.28 ($291K) on 2024-08-19, disclosed to the SEC on 2024-08-20.
Open-market sale of $291k ACAD by EVP, COO, HEAD OF COMMERCIAL. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.28 | 9,534 | $146K | 50.0% |
| 2 | $15.28 | 9,534 | $146K | 50.0% |
| Total | $15.28 avg | 19,068 | $291K | 100% |
| Filing → |
| ACAD | SELL | 2024-04-09 | $46K | — | Filing → |
| ACAD | SELL | 2024-03-27 | $184K | — | Filing → |
| ACAD | SELL | 2024-02-27 | $15K | — | Filing → |